Amgen and Roche target Samsung’s Bioepis in patent suit

01-05-2019

Amgen and Roche target Samsung’s Bioepis in patent suit

jhvephoto / Shutterstock.com

Amgen and Roche have filed a joint patent infringement claim against Samsung’s biopharmaceutical company Bioepis.


Amgen, Roche, Samsung Bioepis, biosimilar, chronic diseases, patent infringement

LSIPR